Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Triple Negative Breast Cancer × camrelizumab × Breast × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 21 Breast Neoplasms 15 Neoplasm Metastasis 2 Her-2 Negative Breast Cancer 1 HER2-negative Breast Cancer 1 Gastrointestinal Neoplasms 1 BRCA-Mutated Breast Carcinoma 1 Advanced Triple Negative Breast Cancer 1

Interventions

lenvatinib 1 camrelizumab 1 apatinib 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1 ALT-803 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06849492 2025-02-27

SHIFT-001

Fudan University

Phase 2 Not yet recruiting

Advanced Triple Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡